Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function
Luca Santarelli(University of Florida), Mark J.S. Heath(University of Florida), Etienne Sibille(Centre for Addiction and Mental Health), Pierre Blier(Université du Québec à Rimouski), René Hen(New York Psychoanalytic Society and Institute), Pierre C. Debs(University of Florida), Gabriella Gobbi(McGill University)
Cited by 285
Related Papers
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
|The Canadian Journal of Psychiatry|2016|1.1k
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression
|JAMA Psychiatry|2019|780
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Antidepressants recruit new neurons to improve stress response regulation
|Molecular Psychiatry|2011|464